HM
BIO icon

HealthCor Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

HealthCor Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-140,080
Closed -$81.7M – 85
2020
Q4 		$81.7M Buy
+140,080
New +$79.8M 3.15% 12
2018
Q4 		– Sell
-16,240
Closed -$5.08M – 41
2018
Q3 		$5.08M Buy
+16,240
New +$5.04M 0.17% 38
2018
Q2 		– Sell
-102,940
Closed -$25.7M – 55
2018
Q1 		$25.7M Buy
+102,940
New +$26.2M 0.88% 37

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

HealthCor Management's BIO Position: Q1 2021 in Review

HealthCor Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2021, closing a stake of 140,080 shares — an estimated $81.7M sold.

HealthCor Management first reported a position in BIO in Q1 2018 and held it in 3 quarters. The position peaked at $81.7M in Q4 2020. 492 funds tracked by Wall St. Rank hold BIO as of Q1 2021.

  • HealthCor Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2021 after selling out during the quarter.
  • HealthCor Management sold 140,080 Bio-Rad Laboratories Class A shares in Q1 2021, an estimated $81.7M.
  • HealthCor Management first reported a position in Bio-Rad Laboratories Class A in Q1 2018 and held it in 3 quarters.
  • HealthCor Management's Bio-Rad Laboratories Class A position peaked at $81.7M in Q4 2020.
  • 492 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2021.

Based on HealthCor Management's 13F filing for Q1 2021, filed 17 May 2021.